430
Participants
Start Date
March 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
July 31, 2012
Dalfampridine-ER 5mg
5mg, twice daily
Dalfampridine-ER 10mg
10mg, twice daily
Placebo
placebo, twice daily
North Central Neurology Associates, PC, Cullman
Phoenix Neurological Associates, Ltd, Phoenix
Arizona Neurological Institute, Sun City
Clinical Research Advantage Inc., Tempe
Sutter East Bay Physicians Medical Foundation, Berkeley
Neuro-Pain Medical Center, Inc., Fresno
Loma Linda University Medical Center, Loma Linda
Collaborative NeuroScience Network, Inc., Long Beach
University of California Davis Medical Center, Sacramento
Mount Sinai Rehabilitation Hospital, Hartford
Georgetown University Hospital, Washington D.C.
Neurology Associates, PA, Maitland
University of Miami School of Medicine, Dept. of Neurology, Miami
Neurological Associates, Pompano Beach
Neurologique Foundation, Inc., Ponte Vedra
Negroski, Sutherland and Hanes Neurology, Sarasota
Suncoast Neuroscience Associates, Inc., St. Petersburg
Tallahassee Neurological Clinic, PA, Tallahassee
Axiom Clinical Research of Florida, Tampa
The Multiple Sclerosis Center of Vero Beach, Vero Beach
Sheperd Center, Inc., Atlanta
Northwestern University, Chicago
Consultants in Neurology Ltd., Northbrook
Indiana University School of Medicine, Indianapolis
Josephson Wallack Munshower Neurology, PC, Indianapolis
Methodist Plaza Specialty, Des Moines
Ruan Neurology Clinic and Research Center, Des Moines
The University of Kansas Medical Center, Kansas City
Associates in Neurology, PSC, Lexington
University of Maryland, Maryland Center for Multiple Sclerosis, Baltimore
Lahey Clinic, Lexington
Springfield Neurology Associates, LLC, Springfield
Wayne State University, Detroit
Advanced Neurology Specialists, Great Falls
Veterans Administration Sierra Neveda Health Care System, Reno
Upstate Clinical Research, LLC, Albany
NYU Langone Medical Center MS Comprehensive Care Center, New York
Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates, Patchogue
Island Neurological Associates, PC, Plainview
University of Rochester Medical Center, Rochester
PMG Research of Charlotte, Charlotte
The Neurological Institute, PA, Charlotte
PMG Research of Hickory, LLC, Hickory
Raleigh Neurology Associates, Raleigh
PMG Research of Winston-Salem, Winston-Salem
Altru Health System Clinic, Grand Forks
Northern Ohio Neuroscience, LLC, Bellevue
Cleveland Clinic Foundation, Cleveland
Neurological Research Institute, Columbus
Ohio State University, Columbus, Columbus
Neurology Specialists, Inc., Dayton
OMRF Multiple Sclerosis Center of Excellence, Oklahoma City
Oregon Health and Science University, Portland
Providence Multiple Sclerosis Center, Portland
The Pennsylvania State University, Milton S. Hershey Medical Center, Hershey
Hospital of the University of Pennsylvania, Philadelphia
Temple University School of Medicine, Philadelphia
The Neurology Foundation, Inc., Providence
Wesley Neurology Clinic, PC, Cordova
Advanced Neurosciences Institute, Franklin
Sibyl E. Wray, MD, Neurology, PC, Knoxville
Texas Neurology, PA, Dallas
Kelsey-Seybold Clinic, Houston
Maxine Mesinger Multiple Sclerosis Clinic; Baylor College of Medicine, Houston
Fletcher Allen Health Care, Burlington
Hampton Roads Neurology, Newport News
Neurological Associates, Richmond
Virginia Commonwealth University, Richmond
Swedish Neuroscience Institute, Seattle
Aurora Saint Luke's Medical Center, Milwaukee
Lead Sponsor
Acorda Therapeutics
INDUSTRY